StageZero Life Sciences Ltd Capital Reinvestment Ratio

Latest as of March 2015: 0.00x

StageZero Life Sciences Ltd capital reinvestment ratio. StageZero Life Sciences Ltd (SZLS) has a Capital Reinvestment Ratio of 0.00x as of March 2015, meaning it reinvests 0% of its operating cash flow (CA$187.19K) in capital expenditures (CA$608.14). See SZLS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

CA$187.19K

CAD

Capital Expenditures

CA$608.14

CAD

Data as of

Mar 2015

Most recent filing

StageZero Life Sciences Ltd Capital Reinvestment Ratio by Year (None–None)

StageZero Life Sciences Ltd capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see SZLS cash flow metrics.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow